Posts Tagged ‘Life Sciences’

  ZS Associates, a global company that offers sales and marketing solutions to a variety of industries, has released its 2015 annual report, which takes a comprehensive look at how pharmaceutical companies are marketing to physicians. 

  The California Life Sciences Association released a new report that proves the Golden State, once again, is at the top of its game when it comes to life sciences. 

  While we work in an industry in which we aim to treat patients, rich or poor, we live in a world where money is often deemed king. And, with an influx of financial investments pouring into newer pharmaceutical and biotechnology companies, people are jumping ship more than ever, making it harder for big pharma […]

  “…a news organization can be most nimble when it is built organically for the digital age.” – John Henry That’s what STAT is. John Henry, the owner of the The Boston Globe, Boston Red Sox, Liverpool Football Club, and Roush Fenway Racing, just launched a new digital publication that’ll solely cover the life sciences […]

Reading a recent LinkedIn Pulse post from Genentech’s VP of IT Americas, Cindy Elkins, made me smile. She said so many good things. Cindy discussed the IT landscape at the company, arguably the most famous biotech (ever!), and how the IT organization impacts employees and patients on many different levels. 

  Last week, Perficient announced that it purchased Rise Foundation, a pre-configured and enhanced version of Microsoft SharePoint, from Blue Rooster. Rise Foundation provides companies with an intranet solution that has the look and feel users expect in today’s digital world. In addition to the impressive UI, the solution enables companies to be more productive […]

  I recently read an article from McKinsey & Company about the digital revolution that needs to occur in order for the life sciences industry to be successful in today’s age. This is the same digital revolution that helped transform other industries, such as financial and retail. Like I mentioned in one of my previous blog […]

  In 2009, the cost for a consumer to sequence his or her genome was $49,000. It’s all the way down to $1,000 today. As the price continues to become more affordable, the frequency of the average Joe sequencing his genome will likely increase. However, many individuals are wary of the idea of knowing more […]

  Now that October is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in September – they’re ranked in order of popularity, with number one being the most viewed piece. 

  Digital transformation (DT), the concept of leveraging digital technologies to engage with constituents (e.g., customers, patients, employees, or partners) is vital in today’s world. The audience you’re targeting expects communication to be easy and information to be readily available at any time. If they can’t get what they want from you, they’ll go somewhere […]

  We often hear the term “rare disease,” yet many of us still wonder exactly how “rare” is defined. In a recent blog post, Dr. Jonathan Goldsmith, the FDA’s Associate Director for Rare Diseases, shared some staggering statistics, as well as insights into how the FDA is making it easier to develop drugs for unusual […]

  It seems like every other day we’re reading about pharmaceutical companies developing mobile apps, or at the very least, investing in companies that develop them. And that’s for good reason: They work. They help researchers learn about disorders. They help educate patients on their conditions and provide treatment recommendations. They help with patient adherence. […]